Researchers publish the first data on the treatment of an age-related disease with drugs called senolytics. The results in patients with deadly idiopathic pulmonary fibrosis are encouraging and indicate the feasibility of larger clinical trials.
Researchers publish the first data on the treatment of an age-related disease with drugs called senolytics. The results in patients with deadly idiopathic pulmonary fibrosis are encouraging and indicate the feasibility of larger clinical trials.